copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Cardiac Amyloidosis: A Hidden Cause of Heart Failure Is Now . . . Both types of cardiac amyloidosis can lead to heart failure, as well as heart rhythm disorders and valve disease Early Signs of Cardiac Amyloidosis “The most common sign of cardiac amyloidosis is when the heart wall is very thick,” says Dr O’Neill
Cardiac amyloidosis: Treatment and prognosis - UpToDate Amyloid deposits can occur in a variety of organs, but morbidity and mortality from amyloid deposition most commonly occur when the heart, kidney, liver, or autonomic nervous system are affected (See "Overview of amyloidosis" ) This topic will review the treatment and prognosis of cardiac amyloidosis
Cardiac amyloidosis: epidemiology, diagnosis and therapy Cardiac amyloidosis is an infiltrative cardiomyopathy caused by accumulation in the heart interstitium of amyloid fibrils formed by misfolded proteins Amyloid cardiomyopathy is an underestimated cause of heart failure and cardiac arrhythmias Two types of amyloid commonly infiltrate the heart: immunoglobulin light chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis Heightened
Cardiac Amyloidosis Clinic - Overview - Mayo Clinic A team approach At the Cardiac Amyloidosis Clinic, doctors who specialize in blood conditions (hematologists), the heart (cardiologists), imaging (radiologists), anatomic pathology, computational biology, neurology, nephrology and hypertension, and other areas work together to provide excellent, comprehensive care
Focus on Heart Failure | Cardiac Amyloidosis: Seek and Ye May . . . Cardiac amyloidosis is becoming increasingly recognized as an etiology for heart failure (HF) Most cases of amyloid cardiomyopathy will fall into one of two categories: light-chain amyloid (AL) amyloidosis resulting from misfolding of monoclonal immunoglobulin light chains or transthyretin
Heart Failure Management of Patients with Amyloid . . . Abstract Cardiac amyloidosis (CA) can lead to progressive heart failure (HF) by depositing insoluble amyloid fibrils within the myocardial extracellular space, resulting in an infiltrative and restrictive cardiomyopathy Although CA was previously perceived as rare and incurable, recent advances in diagnostics and emerging therapies have been changing this outlook It is crucial to spread